Vivo Capital and Merck

Selected healthcare news for the capital firm - Vivo Capital, and the company - Merck. We have 16 shared news items for this connection to-date. Based on the volume of shared news, it's source, placement and other factors, this connection is scored as strong.  Vivo Capital shares healthcare news with Preventice, Preventice Solutions, Biotech, OrbiMed and dozens of others. Merck shares news with Pfizer, Novartis, AstraZeneca, GlaxoSmithKline, Thermo Fisher and hundreds of others.

Selected Headlines

Date Headline (link) Source Relevant Snippet
12/23/2020 Here are the top 5 Houston startup venture capital deals in 2020 ... Vivo Capital along with support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific, and the Samsung Catalyst Fund.The funds were raised in order "to accelerate investment in salesforce expansion, technology and product innovation and further development of clinical evidence supporting its flagship solution," according to the news release."We are pleased to have Vivo Capital and Novo Holdings as new investors, and with this funding we ...
12/23/2020 Texas expert: Coworking in Houston isn’t going away — it's evolving ... Vivo Capital along with support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific, and the Samsung Catalyst Fund.The funds were raised in order "to accelerate investment in salesforce expansion, technology and product innovation and further development of clinical evidence supporting its flagship solution," according to the news release."We are pleased to have Vivo Capital and Novo Holdings as new investors, and with this funding we ...
12/22/2020 Ambyint's $15M series B - InnovationMap ... Vivo Capital along with support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific, and the Samsung Catalyst Fund.The funds were raised in order "to accelerate investment in salesforce expansion, technology and product innovation and further development of clinical evidence supporting its flagship solution," according to the news release."We are pleased to have Vivo Capital and Novo Holdings as new investors, and with this funding we ...
7/15/2020 Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital PR Newswire Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence News provided by Jul 15, 2020, 09:30 ET Share ... S, as well as significant support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific and Samsung Catalyst Fund. "Vivo is extremely pleased to partner with Jon Otterstatter and his management team, Merck ...
7/15/2020 Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital PR Newswire Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence News provided by Jul 15, 2020, 09:30 ET Share ... S, as well as significant support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific and Samsung Catalyst Fund. "Vivo is extremely pleased to partner with Jon Otterstatter and his management team, Merck ...
7/15/2020 Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital PR Newswire Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence News provided by Jul 15, 2020, 09:30 ET Share ... S, as well as significant support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific and Samsung Catalyst Fund. "Vivo is extremely pleased to partner with Jon Otterstatter and his management team, Merck ...
7/15/2020 Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital PR Newswire Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence News provided by Jul 15, 2020, 09:30 ET Share ... S, as well as significant support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific and Samsung Catalyst Fund. "Vivo is extremely pleased to partner with Jon Otterstatter and his management team, Merck ...
7/15/2020 Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital PR Newswire Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence News provided by Jul 15, 2020, 09:30 ET Share ... S, as well as significant support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific and Samsung Catalyst Fund. "Vivo is extremely pleased to partner with Jon Otterstatter and his management team, Merck ...
7/15/2020 Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital PR Newswire Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence News provided by Jul 15, 2020, 09:30 ET Share ... S, as well as significant support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific and Samsung Catalyst Fund. "Vivo is extremely pleased to partner with Jon Otterstatter and his management team, Merck ...
7/15/2020 Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital PR Newswire Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence News provided by Jul 15, 2020, 09:30 ET Share ... S, as well as significant support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific and Samsung Catalyst Fund. "Vivo is extremely pleased to partner with Jon Otterstatter and his management team, Merck ...
7/15/2020 Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital PR Newswire Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence News provided by Jul 15, 2020, 09:30 ET Share ... S, as well as significant support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific and Samsung Catalyst Fund. "Vivo is extremely pleased to partner with Jon Otterstatter and his management team, Merck ...
7/15/2020 Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital PR Newswire Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence News provided by Jul 15, 2020, 09:30 ET Share ... S, as well as significant support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific and Samsung Catalyst Fund. "Vivo is extremely pleased to partner with Jon Otterstatter and his management team, Merck ...